Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2023 Apr 15;199(3):589–601. doi: 10.1007/s10549-023-06937-9

Fig. 2.

Fig. 2.

Kaplan-Meier survival plots comparing ER+ patients (A) above the upper quartile of RET expression (high RET) relative to those below (low RET) or (B) above the upper quartile of both RET and GDNF expression (high RET/GDNF) relative to all others (non-high RET/GDNF) by overall survival, progression-free survival, disease-free survival, and disease-specific survival.